Prohance Multipack

Active Ingredient(s): Gadoteridol
FDA Approved: * October 9, 2003
Pharm Company: * BRACCO
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Prohance Multipack Overview

Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system. It is sold under the brand name ProHance. References .mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//")right 0.1em cent...

Read more Prohance Multipack Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Prohance Multipack Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 279.3mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Prohance Multipack: (1 result)

Sorted by National Drug Code
  • 0270-1111 Prohance 279.3 mg/ml Intravenous Injection, Solution by Bracco Diagnostics Inc.

Other drugs which contain Gadoteridol or a similar ingredient: (1 result)